Detalhe da pesquisa
1.
Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial.
Ann Oncol
; 34(3): 251-261, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36535566